Aravive, Inc. Common Stock
ARAV
ARAV was delisted on the 26th of January, 2024.
55 hedge funds and large institutions have $247M invested in Aravive, Inc. Common Stock in 2014 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 27 increasing their positions, 13 reducing their positions, and 8 closing their positions.
108% more repeat investments, than reductions
Existing positions increased: 27 | Existing positions reduced: 13
0% more funds holding
Funds holding: 55 → 55 (0)
0% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 8
24% less capital invested
Capital invested by funds: $323M → $247M (-$76.4M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$34.1M |
| 2 |
KCM
Kingdon Capital Management
New York
|
+$3.86M |
| 3 |
PA
Perceptive Advisors
New York
|
+$3.79M |
| 4 |
PHS
PFM Health Sciences
San Francisco,
California
|
+$3.73M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$3.66M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RCM
RA Capital Management
Boston,
Massachusetts
|
-$6.71M |
| 2 |
Morgan Stanley
New York
|
-$1.78M |
| 3 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
-$1.4M |
| 4 |
TCM
Tygh Capital Management
Portland,
Oregon
|
-$1.19M |
| 5 |
Norges Bank
Oslo,
Norway
|
-$424K |
ARAV Hedge Fund Activity: Q3 2014 in Review
55 of the 3,446 institutional investors tracked by Wall St. Rank reported a position in Aravive, Inc. Common Stock (ARAV) for Q3 2014, worth a combined $247M — down 24% from $323M a quarter earlier.
Fund positioning in ARAV was balanced in Q3 2014: 8 funds opened new positions, 8 closed out, 27 added to existing stakes and 13 trimmed.
The largest buyer was Fidelity Investments, adding an estimated $34.1M. The largest seller was RA Capital Management, cutting an estimated $6.71M.
- 55 institutional investors held Aravive, Inc. Common Stock (ARAV) as of Q3 2014, unchanged from Q2 2014.
- Funds reported $247M of Aravive, Inc. Common Stock stock for Q3 2014, down 24% quarter-over-quarter.
- 8 funds opened new Aravive, Inc. Common Stock positions in Q3 2014 and 8 closed out, a net change of 0 holders.
- The largest Aravive, Inc. Common Stock buyer in Q3 2014 was Fidelity Investments, an estimated $34.1M added.
- The largest Aravive, Inc. Common Stock seller in Q3 2014 was RA Capital Management, an estimated $6.71M sold.
Based on aggregated 13F filings for Q3 2014.